SUMMIT THERAPEUTICS, INC.
Updates & Highlights
Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Post-TKI Therapy
Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonesc...
Business Wire · 6 days ago
Summit Therapeutics (NASDAQ:SMMT) Reaches New 12-Month Low - Should You Sell?
Summit Therapeutics (NASDAQ:SMMT) Reaches New 12-Month Low - Should You Sell? - Read more on MarketBeat
MarketBeat · 1 day ago
Summit Therapeutics: PDUFA Coming, But Is It Good Enough? (Rating Upgrade) (NASDAQ:SMMT)
Summit Therapeutics: PDUFA Coming, But Is It Good Enough? (Rating Upgrade) (NASDAQ:SMMT) - Read more on Seeking Alpha
Seeking Alpha · 5 days ago
Recent Openings
View all 1 jobsCulture & Mission
Summit Therapeutics, Inc. is building innovative AI solutions with a focus on collaboration and excellence. Join a team of talented engineers working on cutting-edge technology.
Office-Based
Benefits & Perks
📈
Equity/Stock Options
Ownership in the company
📚
Learning Budget
Professional development
💰
Competitive Salary
Market-rate compensation
🏥
Health Insurance
Medical, dental & vision
🏠
Remote Work
Work from anywhere flexibility
🏖️
Generous PTO
Paid time off
Tech Stack
Data Science Ai
Core Values
🎯
Innovation
Pushing boundaries in AI/ML technology
🤝
Collaboration
Working together to achieve more
⚡
Excellence
Striving for the highest quality
🌍
Impact
Making a difference in the world
Office Locations
Menlo Park, CA
Menlo Park
United States
Team
Team information coming soon